Featuring presentation videos and accompanying slides: Take one day out to discover what the future holds for Metastatic Malignant Disease of Undefined Primary Origin (MUO)/Cancer of Unknown Primary (CUP) service delivery. You will hear from experts on how to approach the latest developments, the complexities of investigations and new treatment planning options. During this informative, engaging and structured online course you will benefit from the latest national updates, networking with your NHS MUO/CUP peers and having the time to reflect on the effectiveness of your patient pathways.
SBK Healthcare would like to thank the Cancer of Unknown Primary Foundation - Jo's friends for sponsoring this unique online forum.
If you would like to attend a future event on this topic, please email our Customer Service Team or telephone 01732 897799. They will be happy to assist you
A full list of all upcoming oncology focussed events can be viewed here >>
3.5 hours Continuing Professional Development: what you will learn
With a focus on collaborative working and implementing the latest developments, this online course is not to be missed! View the conference video and refocus on:
- Whole Genome Sequencing (WGS) and its role in standardising MUO/CUP care
- Exploring the latest research for comparing genomic CUP diagnostic techniques
- Utilising the electronic Holistic Needs Assessment (eHNA)
- Bridging the gap between your MUO/CUP and acute oncology services
- Collaborating with Rapid Diagnostic Centres
- Developing and progressing effective and robust pathways
- Improving imaging and understanding the radiologist perspective
Meet your education and training needs in your own time
Packed with examples of best practice, novel ideas and expert advice, plus benefit from:
- 3.5 CPD hours of presentation and speaker Q&A
- Featuring engaging video and accompanying slides
- Available at £299 + VAT for NHS and public sector professionals
- Download and view in your own time
- CPD Certificate issued to you after viewing the video
Introduction and chair’s opening remarks
Dr Sally Clive, Consultant Medical Oncologist – Lower GI Cancer and CUP, Edinburgh Cancer Centre, NHS Lothian
|Whole Genome Sequencing (WGS)|
Standardising care for CUP patients through Whole Genome Sequencing (WGS)
Dr Pavel Bezecny, Medical Oncologist, Blackpool Teaching Hospitals NHS Foundation Trust
Latest research developments: comparing genomic diagnostic techniques
Dr Natalie Cook, Honorary Consultant in Medical Oncology, Senior Clinical Lecturer and Clinical Lead, Experimental Cancer Medicine Team (ECMT), Manchester Experimental Cancer Medicine Centre (ECMC), The University of Manchester and The Christie NHS Foundation Trust
Update from CUP Foundation
John Symons, Director, CUP Foundation
Questions and answers with your speakers
|Ensuring personalised care|
Analysing patient prognostic factors for MUO/CUP patients
Dr Mark Stares, Senior Clinical Research Fellow and Honorary Consultant in Medical Oncology, University of Edinburgh and Edinburgh Cancer Centre, NHS Lothian
Questions and answers with your speakers
Understanding the role of Rapid Diagnostic Centres within the MUO/CUP diagnostic pathway
Dr Roger Prudham, Clinical Director, Northern Care Alliance Rapid Diagnostic Centre
Questions and answers with your speakers
Case study: Bridging the gap between your MUO/CUP and acute oncology services
Myer Lawrence, Lead Nurse, Acute Oncology Service, East Suffolk and North Essex Foundation Trust
Questions and answers with your speaker
Chair’s closing remarks
First-hand speaker experiences
Dr Clive has been a consultant medical oncologist in Edinburgh since 2007 and specialises in the management of patients with cancers of unknown primary (CUP) and the oncological management of colorectal cancer. She is an active clinical researcher, is involved in clinical trials in both colorectal cancer and CUP and is deputy chair of the NCRI CUP subgroup. Since 2010 Sally has worked alongside a multidisciplinary team to develop the CUP service in Lothian, which was the first of its kind in Scotland. The team has evolved in order to improve patient pathways, patient experience and patient outcomes and now takes direct malignancy of undefined primary origin (MUO)/CUP referrals from GPs and from clinicians across South East Scotland. Analysis of our detailed MUO/CUP biobank of over 1250 patients has allowed us to explore pathways, prognostic factors and biological indicators of outcome in all patient groups. Sally is keen to improve pathways to cancer diagnosis and is part of the oversight group for the new Scottish Rapid Cancer Diagnostic Services. She is also interested in systemic anticancer therapy (SACT) governance, chaired the Lothian Cancer Therapeutics and Quality Assurance Committees for 14 years and now chairs the Scottish National Cancer Medicine Advisory Group (NCMAG).
Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at The Christie NHS Foundation Trust/Division of Cancer Sciences, University of Manchester. She is also the clinical lead for Manchester Experimental Cancer Medicine Centre. She previously trained in Medical Oncology in Cambridge, UK, where she completed a PhD, funded by a CRUK Clinical Training fellowship. In 2012, she was awarded the Rothwell Jackson Postgraduate Travelling Fellowship and travelled to Canada to undertake a 2 year drug development research fellowship, based at the University of Toronto and Princess Margaret Cancer Centre. In her current position she is co-investigator on a portfolio of over 50 early phase clinical trials, and is a Chief or Principal Investigator on over 20 trials. She has research interests in precision medicine, colorectal cancer and carcinoma of unknown primary site.
Following graduation from the University of Veterinary Medicine in Brno and the Medical University in Vienna, Dr Bezecny completed his training in General Practice in Austria in 2001. He then trained in Medical Oncology in Republic of Ireland (Waterford, Galway, St Vincent’s University Hospital Dublin), Czech Republic (Brno) and United Kingdom (University College London Hospital).
Since 2012 Dr Bezecny has been working as a Consultant Medical Oncologist at Royal Preston Hospital and Blackpool Victoria Hospital. Dr Bezecny treats patients with breast, lung, upper gastrointestinal cancers and cancers of unknown primary. He is actively promoting clinical research as is a co-author of multiple studies published over recent years.
Dr Bezecny is a member of the European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and the European Organization for Research and Treatment of Cancer (EORTC). He holds the ESMO Certification in Medical Oncology.
Mark is an academic medical oncologist working in Edinburgh. His clinical focus is the management of renal cell carcinoma and melanoma. Mark’s academic interests revolve around the development of detailed real-world clinical datasets to support research activities in several cancers, including cancer of unknown primary. A specific focus of his group has been investigating the utility of routinely collected clinical information to inform patient management.
Dr Prudham qualified from St Bartholomew’s Hospital in 1992 he then returned North to train in the North West, predominantly in Salford and North Manchester. He gained specialist accreditation in gastroenterology in 2000 and the commenced his first consultant post.
He has been a consultant gastroenterologist in Fairfield since 2001. Dr Prudham has also held a variety of senior leadership appointments including Clinical Director, Deputy Medical Director and Lead Cancer Clinician. He is currently the Chair of the Greater Manchester Combined Authority Information Board, Caldicott Guardian, Lead Clinician for the Northern Care Alliance Rapid Diagnostic Centre and Lead Cancer clinician for the Northern Care Alliance group of hospitals.
Dr Prudham is an expert colonoscopist and his main clinical interest is advanced colonoscopy, bowel cancer screening and complex polypectomy. He has led the local screening programme since its inception in 2007. He also provides other expert upper GI endoscopy services both diagnostic and therapeutic such as balloon dilatation and PEG insertion.
Dr Prudham's work in helping establish one of the first Rapid Diagnostic Centres in the country has provided him with specific expertise in the rapid assessment of non-specific symptoms suggestive of cancer, a new and vital service.
- £299 + VAT for you to download and view in your own time
- Click on 'Book Place' and complete your details
Past attendee feedback
"Excellent to network with so many people with an interest in MUO/CUP and have this amount of experience in one forum. Very valuable to have such updates and work with others with the same interest to improve pathways together"Enhancing your MUO/CUP Pathways, March 2023
"Excellent presentations regarding genome sequencing in CUP patients, including the challenges faced regarding the logistics of sampling, time taken to get results, and difficulty accessing targeted treatments for CUP patients"Enhancing your MUO/CUP Pathways, March 2023
"This was my first experience of a full-day online forum/event. It worked exceptionally well! Great organisation from SBK staff, seamless movement into breakout rooms. Adequate breaks away from screen/lunch break. All slides & speakers clear"Enhancing your MUO/CUP Pathways, March 2023
"All the speakers were very professional and had a lot of information to share with the group"Enhancing your MUO/CUP Pathways, March 2023
"Wonderful, very collaborative and helpful to meet with others in this very specialist area"Enhancing your MUO/CUP Pathways, March 2023
"Very well organised, all speakers were great and topics discussed were relevant to my role. Informative session"Enhancing your MUO/CUP Pathways, March 2023
"Very well organised, well delivered and presented. I have benefitted greatly from today and would love to attend future study days please. Thank you to the whole team"Enhancing your MUO/CUP Pathways, March 2023
“Very well put together, breakout rooms have been really informative - interesting to hear about how other services are run”Enhancing your MUO/CUP Pathways, March 2023
If you purchase and view the presentation video and accompanying sides, you will be in good company! The following is an insight into the job titles and organisations who came to Enhancing your MUO/CUP Pathways when it was held on Tuesday 7th March: